EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Metabolic challenges and interventions in CAR T cell therapy

Jhan-Jie Peng iD, Limei Wang, Zhiyu Li, Cheng-Lung Ku iD, Ping-Chih Ho iD

Science Immunology · 14.04.2023 · 8 (82)

DOI: 10.1126/sciimmunol.abq3016 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Science Immunology, erschienen am 14.04.2023. Verfasst von Jhan-Jie Peng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Fundamental Oncology, University of Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Neoplasms, Hematologic Neoplasms. Die Arbeit wurde bisher 154-mal zitiert (Crossref) und nennt 167 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor (CAR) T cells have achieved true clinical success in treating hematological malignancy patients, laying the foundation of CAR T cells as a new pillar of cancer therapy. Although these promising effects have generated strong interest in expanding the treatment of CAR T cells to solid tumors, reproducible demonstration of clinical efficacy in the setting of solid tumors has remained challenging to date. Here, we review how metabolic stress and signaling in the tumor microenvironment, including intrinsic determinants of response to CAR T cell therapy and extrinsic obstacles, restrict the efficacy of CAR T cell therapy in cancer treatment. In addition, we discuss the use of novel approaches to target and rewire metabolic programming for CAR T cell manufacturing. Last, we summarize strategies that aim to improve the metabolic adaptability of CAR T cells to enhance their potency in mounting antitumor responses and survival within the tumor microenvironment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHematologic NeoplasmsHumansImmunotherapy, AdoptiveT-LymphocytesTreatment OutcomeTumor Microenvironment

Autor:innen und Institutionen

  • Department of Fundamental Oncology, University of Lausanne, Lausanne, Switzerland.
  • Ludwig Institute for Cancer Research, University of Lausanne, Epalinges, Switzerland.
  • Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
  • Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, P.R. China.

ORCID-Profile: Jhan-Jie Peng, Cheng-Lung Ku, Ping-Chih Ho

Zitieren

APA

Peng, J. J., Wang, L., Li, Z., Ku, C. L., & Ho, P. C. (2023). Metabolic challenges and interventions in CAR T cell therapy. Science Immunology, 8(82). https://doi.org/10.1126/sciimmunol.abq3016

Vancouver

Peng JJ, Wang L, Li Z, Ku CL, Ho PC. Metabolic challenges and interventions in CAR T cell therapy. Science Immunology. 2023;8(82). doi:10.1126/sciimmunol.abq3016

BibTeX
@article{Peng2023,
  author = {Peng, Jhan-Jie and Wang, Limei and Li, Zhiyu and Ku, Cheng-Lung and Ho, Ping-Chih},
  title = {Metabolic challenges and interventions in CAR T cell therapy},
  journal = {Science Immunology},
  year = {2023},
  volume = {8},
  number = {82},
  doi = {10.1126/sciimmunol.abq3016}
}
Kostenlos starten →